A clinically utilized intravenous continuous rate infusion of diltiazem does not significantly decrease systolic function in healthy dogs.
William H WhitehouseJustin D ThomasonDorothy A Thompson-ButlerMegan D KelleyNatalia CernicchiaroMatthew C TannerPublished in: American journal of veterinary research (2023)
A significant decrease in left ventricular systolic function was not appreciated in healthy dogs receiving diltiazem at a clinically accepted intravenous infusion rate at this dosing regimen. Further studies are needed in dogs with cardiac disease.